Table 1

Compilation of meta-analyses showing prevalence of GI symptoms associated with COVID-19

VariableParasa et al 2 Cheung et al 3 Tariq et al 4 Mao et al 5
Studies (n)29607835
Patients (n)4805428312‚ÄČ7976686
All GI symptomsNA18%NA15%
Diarrhoea7%13%12%9%
Nausea/vomiting5%10%9%6%
Abdominal painNA9%6%3%
AnorexiaNA27%22%21%
Stool sample positivity4148.1%NA54%
  • GI, gastrointestinal.